These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11582807)

  • 21. Ribozymes: from mechanistic studies to applications in vivo.
    Ohkawa J; Koguma T; Kohda T; Taira K
    J Biochem; 1995 Aug; 118(2):251-8. PubMed ID: 8543555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 TAR as anchoring site for optimized catalytic RNAs.
    Puerta-Fernandez E; Barroso-del Jesus A; Romero-López C; Berzal-Herranz A
    Biol Chem; 2003 Mar; 384(3):343-50. PubMed ID: 12715885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computer-aided calculation of the local folding potential of target RNA and its use for ribozyme design.
    Sczakiel G; Tabler M
    Methods Mol Biol; 1997; 74():11-5. PubMed ID: 9204415
    [No Abstract]   [Full Text] [Related]  

  • 24. Direct selection of trans-acting ligase ribozymes by in vitro compartmentalization.
    Levy M; Griswold KE; Ellington AD
    RNA; 2005 Oct; 11(10):1555-62. PubMed ID: 16131588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selecting allosteric ribozymes.
    Piganeau N
    Methods Mol Biol; 2012; 848():317-28. PubMed ID: 22315077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and optimization of sequence-specific hairpin ribozymes.
    Romero-López C; Barroso-delJesus A; Puerta-Fernández E; Berzal-Herranz A
    Methods Mol Biol; 2004; 252():327-38. PubMed ID: 15017061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of the hairpin ribozyme for targeting specific RNA sequences.
    Hampel A; DeYoung MB; Galasinski S; Siwkowski A
    Methods Mol Biol; 1997; 74():171-7. PubMed ID: 9204432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. cis-Acting 5' hammerhead ribozyme optimization for in vitro transcription of highly structured RNAs.
    Meyer M; Masquida B
    Methods Mol Biol; 2014; 1086():21-40. PubMed ID: 24136596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterizing ribozyme cleavage reactions.
    Hendry P; McCall MJ; Lockett TJ
    Methods Mol Biol; 1997; 74():221-9. PubMed ID: 9204437
    [No Abstract]   [Full Text] [Related]  

  • 30. Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter.
    Thompson JD; Ayers DF; Malmstrom TA; McKenzie TL; Ganousis L; Chowrira BM; Couture L; Stinchcomb DT
    Nucleic Acids Res; 1995 Jun; 23(12):2259-68. PubMed ID: 7610054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Length variation of helix III in a hammerhead ribozyme and its influence on cleavage activity.
    Hammann C; Martinez E; Moosbauer J; Hormes R; Tabler M
    Antisense Nucleic Acid Drug Dev; 1999 Feb; 9(1):25-31. PubMed ID: 10192286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substitution of non-catalytic stem and loop regions of hammerhead ribozyme with DNA counterparts only increases KM without sacrificing the catalytic step (kcat): a way to improve substrate-specificity.
    Shimayama T; Sawata S; Komiyama M; Takagi Y; Tanaka Y; Wada A; Sugimoto N; Rossi JJ; Nishikawa F; Nishikawa S
    Nucleic Acids Symp Ser; 1992; (27):17-8. PubMed ID: 1283905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional domain-assembly in hairpin ribozymes.
    Komatsu Y; Kanzaki I; Shirai M; Kumagai I; Yamashita S; Ohtsuka E
    J Biochem; 2000 Apr; 127(4):531-6. PubMed ID: 10739942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of hammerhead ribozymes containing non-nucleotidic linkers.
    Thomson JB; Tuschl T; Eckstein F
    Nucleic Acids Res; 1993 Dec; 21(24):5600-3. PubMed ID: 7506829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. tRNAVal-heterodimeric maxizymes with high potential as geneinactivating agents: simultaneous cleavage at two sites in HIV-1 Tat mRNA in cultured cells.
    Kuwabara T; Warashina M; Nakayama A; Ohkawa J; Taira K
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1886-91. PubMed ID: 10051564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of minimised hammerhead ribozymes.
    Hendry P; McCall MJ; Santiago FS; Jennings PA
    Nucleic Acids Res; 1995 Oct; 23(19):3922-7. PubMed ID: 7479037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.
    Chen CJ; Banerjea AC; Harmison GG; Haglund K; Schubert M
    Nucleic Acids Res; 1992 Sep; 20(17):4581-9. PubMed ID: 1408760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ribozymes.
    James HA; Turner PC
    Methods Mol Biol; 1997; 74():1-9. PubMed ID: 9204414
    [No Abstract]   [Full Text] [Related]  

  • 39. Artificial ligase ribozymes isolated by a "design and selection" strategy.
    Matsumura S; Ikawa Y
    Methods Mol Biol; 2015; 1316():113-25. PubMed ID: 25967057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of properties of natural catalytic RNA to design and synthesize functional ribozymes.
    Phylactou LA; Darrah C; Everatt L; Maniotis D; Kilpatrick MW
    Methods Enzymol; 2000; 313():485-506. PubMed ID: 10595375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.